Related Experiment Video
Updated: Mar 30, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
Transcription factor Ets-1 links glucotoxicity to pancreatic beta cell dysfunction through inhibiting PDX-1
Fang Chen1, Min Sha1, Yanyang Wang1
1Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing Medical University, 140 Hanzhong Road, Nanjing, 210029, People's Republic of China.
Aims/Hypothesis:
'Glucotoxicity' is a term used to convey the negative effect of hyperglycaemia on beta cell function; however, the underlying molecular mechanisms that impair insulin secretion and gene expression are poorly defined. Our objective was to define the role of transcription factor v-ets avian erythroblastosis virus E26 oncogene homologue 1 (Ets-1) in beta cell glucotoxicity.
Methods:
Primary islets and Min6 cells were exposed to high glucose and Ets-1 expression was measured. Recombinant adenovirus and transgenic mice were used to upregulate Ets-1 expression in beta cells in vitro and in vivo, and insulin secretion was assessed. The binding activity of H3/H4 histone on the Ets-1 promoter, and that of forkhead box (FOX)A2, FOXO1 and Ets-1 on the Pdx-1 promoter was measured by chromatin immunoprecipitation and quantitative real-time PCR assay.
Results:
High glucose induced upregulation of Ets-1 expression and hyperacetylation of histone H3 and H4 at the Ets-1 gene promoter in beta cells. Ets-1 overexpression dramatically suppressed insulin secretion and biosynthesis both in vivo and in vitro. Besides, Ets-1 overexpression increased the activity of FOXO1 but decreased that of FOXA2 binding to the pancreatic and duodenal homeobox 1 (PDX-1) homology region 2 (PH2), resulting in inhibition of Pdx-1 promoter activity and downregulation of PDX-1 expression and activity. In addition, high glucose promoted the interaction of Ets-1 and FOXO1, and the activity of Ets-1 binding to the Pdx-1 promoter. Importantly, PDX-1 overexpression reversed the defect in pancreatic beta cells induced by Ets-1 excess, while knockdown of Ets-1 prevented hyperglycaemia-induced dysfunction of pancreatic beta cells.
Conclusions/Interpretation:
Our observations suggest that Ets-1 links glucotoxicity to pancreatic beta cell dysfunction through inhibiting PDX-1 expression in type 2 diabetes.
Insights
High glucose harms pancreatic beta cells by increasing Ets-1. This factor suppresses insulin, linking glucotoxicity to type 2 diabetes dysfunction via PDX-1 inhibition.
Area of Science:
- Endocrinology
- Molecular Biology
- Diabetes Research
Background:
- Glucotoxicity, a consequence of hyperglycemia, impairs pancreatic beta cell function.
- The precise molecular mechanisms underlying glucotoxicity-induced defects in insulin secretion and gene expression remain unclear.
Purpose of the Study:
- To elucidate the role of the transcription factor v-ets avian erythroblastosis virus E26 oncogene homologue 1 (Ets-1) in pancreatic beta cell glucotoxicity.
Main Methods:
- Primary islets and Min6 cells were exposed to high glucose to assess Ets-1 expression.
- Recombinant adenovirus and transgenic mice models were employed to manipulate Ets-1 levels in beta cells.
- Chromatin immunoprecipitation and quantitative real-time PCR were utilized to measure promoter binding activities.
Main Results:
- High glucose upregulated Ets-1 and histone acetylation at the Ets-1 promoter, suppressing insulin secretion and biosynthesis.
- Ets-1 overexpression altered FOXO1 and FOXA2 binding to the PDX-1 promoter, inhibiting PDX-1 expression.
- PDX-1 overexpression rescued Ets-1-induced defects, while Ets-1 knockdown prevented hyperglycemia-induced beta cell dysfunction.
Conclusions:
- Ets-1 acts as a crucial link between glucotoxicity and pancreatic beta cell dysfunction in type 2 diabetes.
- Inhibition of PDX-1 expression by Ets-1 is a key mechanism contributing to beta cell failure under hyperglycemic conditions.
Related Concept Videos
Cell Specific Gene Expression
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Insulin Secretory Vesicles
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Insulin: The Receptor and Signaling Pathways

